All In MedTech

Device Trial Radar · NCT07549737

Effectiveness of Silicone Superabsorbent Polymer Dressings for Chronic Wound Management

A Prospective, Single-arm, Cohort Post Market Clinical Follow Up Investigation to Follow Evolution of the Healing of Exuding Chronic Leg Ulcers Treated With RespoSorb Silicone Border and RespoSorb Silicone Dressings.

Last checked: Nov 19, 2026Latest source record: Apr 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

80

Actual

Start

Jul 17, 2024

Primary completion

Aug 21, 2025

Study completion Aug 23, 2025

Sponsor

Lead sponsor
HARTMANN GROUPNot on our public-company list
Sponsor type
Industry
First posted
Apr 24, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this single arm clinical study is to find out how well two Silicone superabsorbent polymer dressings, RespoSorb Silicone (also known as Zetuvit Plus Silicone) and RespoSorb Silicone Border (also known as Zetuvit Plus Silicone Border), work in treating long lasting wounds on the lower legs or feet. The main goal of the study is to see whether these dressings help reduce wound size over time. The study also looks at whether the dressings improve the condition of the wound and the surrounding skin. In addition, patients are asked about their experience with the dressings, including whether they help reduce pain and how satisfied patients are with the treatment.

Conditions

  • Venous Leg Ulcer (VLU)
  • Diabetic Foot Ulcer (DFU)

Interventions

  • RespoSorb Silicone (RSSil)Device

    RespoSorb Silicone is a Silicone Superabsorbent Polymer (SAP) dressing intended for the management of chronic, exuding lower extremity wounds. The dressing consists of a superabsorbent core designed to absorb and retain wound exudate and a soft silicone contact layer that allows gentle adhesion to the peri-wound skin while minimizing trauma and pain during dressing changes. RespoSorb Silicone is applied directly to the wound bed and secured with an appropriate secondary fixation according to standard clinical practice and the manufacturer's Instructions for Use. Dressing changes are performed as clinically indicated. Treatment is continued for up to 6 weeks or until wound healing, discontinuation, or withdrawal.

  • RespoSorb Silicone Border (RSSB)Device

    RespoSorb Silicone Border is a Silicone Superabsorbent Polymer (SAP) dressing intended for the management of chronic, exuding lower extremity wounds. The dressing combines a superabsorbent core for effective exudate absorption and retention with a soft silicone contact layer to minimize disruption of the wound and peri-wound skin. The dressing includes an integrated adhesive silicone border that provides secure fixation without the need for additional secondary dressings. RespoSorb Silicone Border is applied according to standard clinical practice and the manufacturer's Instructions for Use. Dressing changes are performed as clinically indicated. Treatment is continued for up to 6 weeks or until wound healing, discontinuation, or withdrawal.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Wound area reductionTime frame: Up to 6 weeks (maximum total treatment period), or until wound healing, withdrawal, or discontinuation, whichever occurs first

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • JBS Klinika Spółka Z Ograniczoną Odpowiedzialnością

    Gdansk, Poland

  • MelissaMed Poradnia Chirurgiczna

    Lodz, Poland

  • MIKOMED Spółka Z Ograniczoną Odpowiedzialnością

    Lodz, Poland

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.